Abstract
Libman–Sacks (LS) endocarditis was first described by Libman and Sacks in 1924, and is characterized by sterile, verrucous valvular lesions with a predisposition for the mitral and aortic valves. It is now regarded as both a cardiac manifestation of systemic lupus erythematosus and, in recent years, of the antiphospholipid syndrome (APS). Though typically mild and asymptomatic, LS endocarditis can lead to significant complications, including severe valvular insufficiency requiring surgery, infective endocarditis, and thromboembolic events, such as stroke and transient ischemic events. Improvements in imaging modalities, particularly in echocardiography, have allowed better estimation of the prevalence of the disease, but further investigation is still needed into its pathogenesis, treatment, and association with APS.
Similar content being viewed by others
References
Castro J, Balada E, Ordi-Ros J, Vilardell-Tarres M (2008) The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7:345–351
Crispin JC, Tsokos GC (2008) Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev 7:256–261
Hurst J, von Landenberg P (2008) Toll-like receptors and autoimmunity. Autoimmun Rev 7:204–208
Marmont AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30:145–150
Shoenfeld Y, Twig G, Katz U, Sherer Y (2008) Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 30:74–83
Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205
Youinou P, Renaudineau Y (2007) The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev 7:149–154
Libman E, Sacks B (1924) A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 33:701–707
D’Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR (1985) Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 16:512–514
Hojnik M, George J, Ziporen L, Shoenfeld Y (1996) Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93:1579–1587
Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817–823
Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F (1992) Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 34:69–74
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM (2007) Libman–Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 120:636–642
Asherson RA, Hughes GR (1989) The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. Clin Exp Rheumatol 7:225–228
Espinola-Zavaleta N, Vargas-Barron J, Colmenares-Galvis T, Cruz-Cruz F, Romero-Cardenas A, Keirns C, Amigo MC (1999) Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 137:973–978
Yamamoto H, Iwade T, Nakano R, Mohri M, Amari Y, Noma M (2007) Images in cardiovascular medicine. Numerous small vegetations revealing Libman–Sacks endocarditis in catastrophic antiphospholipid syndrome. Circulation 116:e531–e535
Mandell BF (1987) Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 17:126–141
Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110:1257–1265
Morin AM, Boyer AS, Nataf P, Gandjbakhch I (1996) Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 44:313–316
Mraz-Gernhard SM, Bush TM, Riebman JB (2001) Clinical images: Libman–Sacks endocarditis. Arthritis Rheum 44:2111
Moyssakis I, Tzioufas A, Triposkiadis F, Strateges N, Kyriakidis M (2002) Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus. Clin Cardiol 25:194–196
Hoffer E, Itoua M, Radermecker M, Pierard L (2000) Stenosis of a mechanical mitral prosthetic valve in a patient with systemic lupus erythematosus. Acta Cardiol 55:49–51
Armstrong D, Wright S, McVeigh C, Finch M (2006) Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis? Clin Rheumatol 25:583–584
Tornos MP, Galve E, Pahissa A (1985) Clinical considerations regarding infective Libman–Sacks endocarditis. Int J Cardiol 7:409–412
Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr (2005) Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 95:1441–1447
Pritzker MR, Ernst JD, Caudill C, Wilson CS, Weaver WF, Edwards JE (1980) Acquired aortic stenosis in systemic lupus erythematosus. Ann Intern Med 93:434–436
Kang AH, Graves CR (1999) Libman–Sacks endocarditis in a pregnant woman with acute respiratory distress syndrome. Obstet Gynecol 93:819–821
Appelbe AF, Olson D, Mixon R, Craver JM, Martin RP (1991) Libman–Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol 68:817–818
Taguchi S, Hashimoto K, Sakamoto Y, Okuyama H, Ishii S (2006) A case of mitral valve plasty for Libman–Sacks endocarditis mimicking a cardiac tumor. J Thorac Cardiovasc Surg 132:1465–1467
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638
Menard GE (2008) Establishing the diagnosis of Libman–Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 23:883–886
Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr (2008) Transthoracic versus transesophageal echocardiography for detection of Libman–Sacks endocarditis: a randomized controlled study. J Rheumatol 35:224–229
Shapiro RF, Gamble CN, Wiesner KB, Castles JJ, Wolf AW, Hurley EJ, Salel AF (1977) Immunopathogenesis of Libman–Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis 36:508–516
Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y (1996) Libman–Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5:196–205
Bulkey BH, Roberts WC (1975) Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol 35:305–308
Rose AG, Spracklen FH (1987) Double valve disease in systemic lupus erythematosus. Case report and literature review. Am J Cardiovasc Pathol 1:141–144
Brito FA, Tofani ML, Tofani FA, Kakehasi AM, Lanna CC, Carvalho MA (2004) Libman–Sacks endocarditis and oral anticoagulation. Arq Bras Cardiol 82:378–383
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, J.L., Naguwa, S.M., Cheema, G.S. et al. Revisiting Libman–Sacks Endocarditis: A Historical Review and Update. Clinic Rev Allerg Immunol 36, 126–130 (2009). https://doi.org/10.1007/s12016-008-8113-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-008-8113-y